We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCM:NYSEStellus Capital Investment Corporation Analysis

Data as of 2026-08-31 - not real-time

$8.66

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Stellus Capital Investment Corporation is neutral at $8.66, with no clear ordering between short and long averages. The last 30 days have gained 21.3%. RSI sits at 56.8, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $7.72 and resistance at $8.97.
Valuation screens as undervalued: a P/E of 8.4 sits below the sector average of 16.9. Consensus targets land 16.9% above where the shares trade now. Revenue is contracting at 13.2% on a 30.7% profit margin. The 15.23% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 33.9%, a beta of 0.90 and a maximum drawdown of 53.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

HOUSTON, Aug. 10, 2026 /PRNewswire/ -- Stellus Capital Investment Corporation NYSE: SCM "Stellus", "we", or the...Updated Jul 29, 2026 0 Stellus Capital Investment Corporation Schedules Second Quarter 2026 Financial Results...HOUSTON, July 16, 2026 /PRNewswire/ -- Stellus Capital Investment Corporation the "Company" NYSE: SCM announced that...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 10.10
  • MACD momentum is negative
  • 30-day price change of +21.3%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 8.4 versus sector average of 16.9
  • Dividend yield of 15.23% looks stretched against payout coverage
  • Trading below the 200-day average of 10.10

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 8.4 versus sector average of 16.9
  • Dividend yield of 15.23% looks stretched against payout coverage
  • Analyst targets imply +16.9% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-13.20%
Profit Margin30.66%
P/E Ratio8.4
ROE8.02%
ROA4.07%
Debt/Equity163.35
P/B Ratio0.7
Op. Cash Flow$45.0M
Free Cash Flow$16.4M
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI56.8
Support$7.72
Resistance$8.97
MA 20$8.60
MA 50$8.18
MA 200$10.10
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Target Price$10.13
Upside/Downside16.92%
GradeUndervalued
TypeValue
Dividend Yield15.23%

Risk Assessment

Beta0.90
Volatility33.90%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.